Matthias Baud

Title: Matthias Baud - Innovator in Sulfatase Deficiency Treatments

Introduction

Matthias Baud is a notable inventor based in Southampton, GB. He has made significant contributions to the field of medical treatments, particularly focusing on diseases associated with sulfatase deficiencies. His innovative approach has the potential to improve the lives of many individuals suffering from these conditions.

Latest Patents

Matthias Baud holds a patent for a method aimed at treating diseases associated with sulfatase deficiencies. This method involves administering a therapeutically effective amount of at least one retinoid to individuals suffering from lysosomal storage diseases. Specifically, the compounds tazaroten and bexaroten have shown beneficial effects for these patients. The pharmaceutical compositions that include both active agents provide a ready treatment option, and enhanced results are achieved when at least two active agents are utilized.

Career Highlights

Matthias Baud is affiliated with Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin. His work at this esteemed institution has allowed him to focus on groundbreaking research and development in the medical field. His dedication to improving treatment options for patients with sulfatase deficiencies is commendable.

Collaborations

Some of Matthias Baud's coworkers include Lars Schlotawa and Matthias Kettwig. Their collaboration in research and development has contributed to the advancement of treatments for sulfatase deficiencies.

Conclusion

Matthias Baud's innovative work in the treatment of sulfatase deficiencies highlights the importance of research in developing effective medical solutions. His contributions are paving the way for better health outcomes for individuals affected by these diseases.